The goal of this prospective randomized controlled trial is to investigate the clinical effects of autologous blood pleurodesis in the treatment of pulmonary air leaks on the first postoperative day following VATS pulmonary resections. Patients will through web-based randomization be randomly assigned into intrapleural instillation of autologous blood (intervention) or standard treatment with ordinary chest drainage (control).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Duration of air leakage until sealed.
Timeframe: Through study completion, an average of 3 years.
Duration until chest drain removal.
Timeframe: Through study completion, an average of 3 years.
Duration of hospital stay.
Timeframe: Through study completion, an average of 3 years.